GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -615 | -3,700 | -2,562 | -2,585 | -1,923 |
| Depreciation Amortization | 32 | 307 | 326 | 266 | 90 |
| Other Working Capital | 103 | 604 | 657 | 224 | 1,648 |
| Other Operating Activity | 288 | 1,826 | 940 | 1,555 | 38 |
| Operating Cash Flow | $-192 | $-963 | $-639 | $-540 | $-147 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 220 | N/A | N/A | N/A | 94 |
| Debt Issued | N/A | 977 | 621 | 621 | N/A |
| Debt Repayment | N/A | N/A | -50 | -50 | N/A |
| Common Stock Issued | N/A | 24 | 14 | 4 | N/A |
| Financing Cash Flow | $220 | $1,001 | $585 | $575 | $94 |
| Beginning Cash Position | 92 | 54 | 54 | 54 | 54 |
| End Cash Position | 120 | 92 | N/A | 89 | 1 |
| Net Cash Flow | $28 | $38 | $-54 | $35 | $-53 |
| Free Cash Flow | |||||
| Operating Cash Flow | -192 | -963 | -639 | -540 | -147 |
| Free Cash Flow | -192 | -963 | -639 | -540 | -147 |